Clinical Trials Sponsored by ImmunoPharma AS

Total 358 results

Oslo University Hospital
ImmunoPharma AS

Completed

Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease

Norway
Egil Johnson
ImmunoPharma AS

Completed

Effect of Andosan in Patients With Rheumatoid Arthritis (Andosan-RA)

Rheumatoid Arthritis

Norway
Oslo University Hospital
University of Oslo; ImmunoPharma AS

Completed

Does Medicinal Mushroom Agaricus Blazei Protect Against Allergy and Asthma?

Pollen; Allergy, Asthma
University Hospital, Akershus
Oslo University Hospital; ImmunoPharma AS

Recruiting

Andosan in Allergic and Asthma Patients

Allergic Asthma | Allergic Rhinoconjunctivitis | Immune Tolerance

Norway
Lyell Immunopharma, Inc.

Recruiting

A Study to Investigate LYL845 in Adults With Solid Tumors

Melanoma | Colorectal Cancer | Non-small Cell Lung Cancer

United States
Lyell Immunopharma, Inc.

Recruiting

A Study to Investigate LYL797 in Adults With Solid Tumors

Advanced Breast Cancer | NSCLC | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Recurrent Breast Cancer | TNBC - Triple-Negative Breast Cancer | Relapsed Cancer | NSCLC, Recurrent | Recurrent... and other conditions

United States
ImmuPharma

Completed

A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus (LUPUZOR)

Lupus Erythematosus, Systemic

France, Puerto Rico, Poland, Mauritius, United States, Czechia, Germany, Hungary
ImmuPharma

Completed

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus (IP-006)

Lupus Erythematosus, Systemic

United States, Puerto Rico, France, Mauritius, Czechia, Germany, Hungary
Hefei TG ImmunoPharma Co., Ltd.

Recruiting

A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

China
Lyell Immunopharma, Inc.
ICON plc

Recruiting

A Biomarker Screening Protocol for Participants With Solid Tumors (START)

Triple Negative Breast Cancer | Nonsmall Cell Lung Cancer

United States
Hefei TG ImmunoPharma Co., Ltd.

Recruiting

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Melanoma | Colorectal Cancer | Ovarian Cancer | Triple Negative Breast Cancer

United States
Epax Norway AS
Møreforsking AS

Unknown

Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex) (CetoIndex)

Healthy Volunteers

Norway
Epax Norway AS
Møreforsking AS

Recruiting

Nutritional Study of Fish Oil in Skin Quality in Healthy Women (OPTIHUD)

Skin Health

Norway
Pacertool AS

Not yet recruiting

Pacertool Early Feasibility Study - Safety and Performance

Heart Failure With Reduced Ejection Fraction | Dyssynchrony | Medical Device Performance

Georgia
Serodus AS

Recruiting

SER150 vs Placebo in Diabetic Kidney Disease

Diabetic Kidney Disease

Australia, New Zealand
CardioMech AS

Recruiting

EFS of the CardioMech MVRS

Mitral Regurgitation

United States
Labrida AS

Completed

Treatment of Advanced Periodontitis Using an Oscillating Chitosan Device Versus Regular Curettes Alone

Periodontal Diseases

Norway, Turkey
Revmatismesykehuset AS

Completed

Effect of a Thin Customized Insole in RA

Rheumatoid Arthritis
AlgiPharma AS

Completed

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis (OligoG)

Cystic Fibrosis

United Kingdom, Ireland
Marealis AS

Completed

Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp (MARE)

Hypertension | Blood Pressure

Finland
Revmatismesykehuset AS

Completed

Effect of One Week Self-management Program in Patients With Fibromyalgia

Fibromyalgia

Norway
Picterus AS

Recruiting

Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones (allphones)

Neonatal Jaundice

Norway
SonoClear AS

Recruiting

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Glioblastoma | High Grade Glioma | Low-grade Glioma | Brain Tumour

Germany, Slovakia, Italy
Oncoinvent AS

Active, not recruiting

Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC

Peritoneal Carcinoma | Colorectal Carcinoma

Norway, Sweden
HoloCare AS

Completed

HS2 US Liver Reader Study

Reader Study

United States
Otivio AS

Enrolling by invitation

Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain

Pain | Multiple Sclerosis | Spasticity, Muscle

Norway
BASF AS

Unknown

Hepaxa Management of Non-alcoholic Fatty Liver Disease

NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Fatty Liver

United States
AlgiPharma AS

Completed

A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection (SMR-2591)

Cystic Fibrosis | Burkholderia Infection

Germany
Blueskin AS

Recruiting

A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo (Derma-001)

Psoriasis | Atopic Dermatitis | Vitiligo | Alopecia Areata

Denmark
Biomad AS

Not yet recruiting

Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3

Sars-cov-2

Iraq
Oncoinvent AS

Active, not recruiting

Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

Ovarian Cancer | Peritoneal Carcinomatosis

Belgium, Spain, Norway
Otivio AS

Active, not recruiting

Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain (FO-NP002)

Multiple Sclerosis | Spasticity, Muscle | Pain, Chronic

Sweden
Labrida AS

Completed

Treatment of Mild to Moderate Peri-implantitis Using an Oscillating Chitosan Device

Peri-Implantitis

Norway, Sweden
Smartfish AS

Completed

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia

Cachexia | COPD

Sweden
Biovotec AS

Completed

DermaRep™ Device in the Treatment of Venous Leg Ulcers (DermaRep™)

Venous Leg Ulcer

United Kingdom
Smartfish AS

Completed

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

NSCLC | Cachexia

Italy, Sweden, Croatia, Slovakia
Ayanda AS

Completed

Bioavailability Study of Long Chain Omega-3 Fatty Acids From a Gastric Stable Emulsion

Healthy

Norway
SantoSolve AS

Completed

2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.

Pain | Amputation Stumps

Norway
Ferrosan AS

Completed

Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain

Back Pain

Denmark
Smerud Medical Research International AS
SantoSolve AS

Unknown

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain

Stump Pain

Denmark, Germany, Norway, Russian Federation, United Kingdom
Smerud Medical Research International AS
SantoSolve AS

Unknown

A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee

Pain | Osteoarthritis

United Kingdom, Finland, Poland, Russian Federation
AlgiPharma AS
Smerud Medical Research International AS

Completed

Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis

Cystic Fibrosis

United Kingdom
PCI Biotech AS

Terminated

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer (RELEASE)

Cholangiocarcinoma

United States, Spain, Belgium, Germany, Italy, Denmark, Finland, France, Korea, Republic of, Norway, Poland, Sweden, Taiwan, Ukraine
SoftOx Solutions AS

Completed

Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds

Venous Leg Ulcer | Chronic Leg Ulcer

Denmark
SoftOx Solutions AS

Completed

Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects

Healthy Volunteers | Safety

Denmark
PCI Biotech AS

Completed

A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

Cholangiocarcinoma

Germany, France, Norway, United Kingdom
PCI Biotech AS

Completed

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Healthy Volunteer

United Kingdom
PCI Biotech AS

Completed

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

Head and Neck Neoplasms | Skin Neoplasms

United Kingdom
SoftOx Solutions AS

Unknown

Safety and Performance of SoftOx Wound Irrigation Solution (SWIS) in Acute Wounds (SWIS-01)

Acute Wounds

Denmark
Olympic Seafood AS

Completed

Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure

Adverse Drug Event | Side Effects of Drugs

Finland

Clinical Trials Sponsored by ImmunoPharma AS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations